These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 15430933)
1. [Treatment of hemoblastosis with cytostatic substances]. HAUSMANN K Sang; 1950; 21(4):365-8. PubMed ID: 15430933 [No Abstract] [Full Text] [Related]
2. Comparative clinical studies with new cytostatic agents. ECKHARDT A Acta Unio Int Contra Cancrum; 1960; 16():842-5. PubMed ID: 13819224 [No Abstract] [Full Text] [Related]
3. [Mitotic phases in the peripheral blood in leukemia treated with cytostatic substances]. KIRSCH W Z Gesamte Inn Med; 1950 Jul; 5(13-14):385-6. PubMed ID: 15443674 [No Abstract] [Full Text] [Related]
4. [Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine]. CATTANEO O G Ital Chemioter; 1954; 1(3-4):557-8. PubMed ID: 14391668 [No Abstract] [Full Text] [Related]
5. [Paper electrophoresis of plasma proteins in the hemoblastosis]. DIAZ-RUBIO M; SEGOVIA F Rev Clin Esp; 1956 Jan; 60(1):16-23. PubMed ID: 13336642 [No Abstract] [Full Text] [Related]
6. [Chemical tests of proteins during the course of hemoblastosis]. GERHARTZ H; KESSEL M Dtsch Arch Klin Med; 1955; 202(3):347-67. PubMed ID: 13305367 [No Abstract] [Full Text] [Related]
7. [Pathological anatomy and differentiation of hemoblastosis and reticulosis]. FRESEN O Strahlentherapie; 1953; 91(1):1-34. PubMed ID: 13102063 [No Abstract] [Full Text] [Related]
8. [Cytodiagnosis of hemoblastosis and reticulosis by means of an adenogram]. HROMEC A Neoplasma; 1957; 4(3):238-47. PubMed ID: 13504369 [No Abstract] [Full Text] [Related]
9. [Results and prognosis of cystostatic therapy in hemoblastosis and malignant neoplasms]. RIEGEL R Dtsch Med J; 1955 Apr; 6(8):249-56. PubMed ID: 13241201 [No Abstract] [Full Text] [Related]
10. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine]. STORTI E; MANZINI E G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601 [No Abstract] [Full Text] [Related]
11. [Peculiarities in the course of malignant diseases of the hemopoietic & lymphoreticular systems under cytostatic treatment]. SIEGENTHALER W; KEISER G; ZOLLINGER HU Z Klin Med; 1959; 155(6):568-601. PubMed ID: 13648600 [No Abstract] [Full Text] [Related]
12. [NEW EXPERIENCES IN PROLONGED TREATMENT OF MACROGLOBULINEMIC HEMOBLASTIC DISEASES WITH CYTOSTATIC DRUGS]. KLEMM D Dtsch Med Wochenschr; 1965 Jul; 90():1277-81. PubMed ID: 14314997 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of malignant blood diseases with substances inhibiting mitosis]. MARINONE G Rev Hematol; 1953; 8(4):438-61. PubMed ID: 13167792 [No Abstract] [Full Text] [Related]
14. [Effect of immune sera on leukemic leukocytes in hemoblastosis in children]. MITERA M; VESELY J; STERZL J; RIMAN J; HRUBESOVA M Sb Lek; 1956 May; 58(5):97-119. PubMed ID: 13351526 [No Abstract] [Full Text] [Related]
15. [Myleran, a new cytostatic drug in leukemias]. BOLLAG W Schweiz Med Wochenschr; 1953 Sep; 83(37):872-6. PubMed ID: 13089623 [No Abstract] [Full Text] [Related]
16. [The cytostatic effectiveness of tertiary aliphatic phosphine derivatives in chronic lymphatic leukemias]. SIERING H Verh Dtsch Ges Inn Med; 1959; 65():215-8. PubMed ID: 14446532 [No Abstract] [Full Text] [Related]
17. [Investigation of folic acid antagonist therapy in cancer of hemopoietic organs and leukemia]. BASERGA A Krebsarzt; 1951 Aug; 6(7-8):266-7. PubMed ID: 14862154 [No Abstract] [Full Text] [Related]
18. BIOLOGICAL PROPERTIES OF CELLS OF THE HEMOPOIETIC TISSUE IN LEUKEMIA. TERENTIEVA EI Acta Unio Int Contra Cancrum; 1964; 20():1379-80. PubMed ID: 14242905 [No Abstract] [Full Text] [Related]
19. [ON THE CYTOSTATIC EFFECT OF CHLOROACETAMIDOMETHYL N-CHLOROMETHYLCARBAMATE]. LOEWE H; JUNG F Acta Biol Med Ger; 1964; 13():433-4. PubMed ID: 14251837 [No Abstract] [Full Text] [Related]
20. [The treatment of leukemia, with notes on other severe hematic diseases]. FIESCHI A An Inst Med Trop (Lisb); 1950 Sep; 7(Suppl):177-91. PubMed ID: 14857288 [No Abstract] [Full Text] [Related] [Next] [New Search]